Eye cancers or ocular cancers manifests itself in the eye. Cancer is referred to the uncontrolled growth of the cells, similarly, eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably leading to the formation of tumors. The global eye cancer market is expecting a healthy growth in coming future. The global market is majorly driven by increasing eye cancer patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval, and side effects of the treatment may hinder the growth of the market.

Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4736

The global eye cancer market is expected to grow at a CAGR of ~8.3 % during the forecast period 2017-2023.

Key Players

Some of key the players in the market are GlaxoSmithKline Plc. (U.K.), AstraZeneca Plc. (U.K.), Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), Bayer AG (Germany), Amgen, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), , F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.), Sanofi (France), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Oncomed Pharmaceuticals (U.S.) and Immunomedics (U.S.).

Segmentation

The global eye cancer market is segmented on the basis of types, treatment and end users.

On the basis of treatment, the market is categorised into chemotherapy, surgery & radiation therapy, targeted therapy, hormone therapy, biologic therapy, and other. Chemotherapy is further segmented into anthracyclines, taxanes, antimetabolites, and alkylating agents. Target therapy is sub segmented into monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others.

On the basis of types, the market is segmented into intraocular cancer, squamous cell cancer, rhabdomyosarcoma, and others. Intraocular cancer is further segmented into melanoma of the eye, lymphoma of the eye, and eye cancers in children.

On the basis of end users, the market is segmented into hospital & clinics, ambulatory care centers and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/eye-cancer-market-4736

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: [email protected]